Skip to main content
. 2010 Dec 22;5(12):e15737. doi: 10.1371/journal.pone.0015737

Figure 2. The combined evaluation of RB1CC1, RB1 and p53 provide a significant prediction of prognoses in non-triple-negative breast cancers.

Figure 2

Kaplan-Meier method with a log-rank test was performed in 236 patients with non-triple-negative breast cancers (Chi-Square value = 18.543, p<0.0001).